Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Coombes

Showing results (281-290 of 334) with videos related to

Pageof 34
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapyMark S Carey, Roshan Agarwal, Blake Gilks, et al.
The Journal of Molecular Diagnostics : JMD|August 11, 2007
Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technologyLynne V Abruzzo, Lynn L Barron, Keith Anderson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2010
Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progressionJoan H Admirand, Ronald J Knoblock, Kevin R Coombes, et al.
Annals of Surgery|May 21, 2024
Extracellular Vesicle- MDM2 -DNA as a Potential Liquid Biopsy Biomarker for Disease Identification in Retroperitoneal LiposarcomaFederica Calore, Lucia Casadei, Patricia D Sarchet, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2016
Risk Factors of <sup>131</sup>I-Induced Salivary Gland Damage in Thyroid Cancer PatientsBrynn Hollingsworth, Leigha Senter, Xiaoli Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentationThomas Karn, Lajos Pusztai, Eugen Ruckhäberle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2011
Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patientsYang Xie, Guanghua Xiao, Kevin R Coombes, et al.
British Journal of Cancer|January 1, 1997
Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significanceA J Desai, Y A Luqmani, J E Walters, et al.
The Journal of Molecular Diagnostics : JMD|January 1, 2013
Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypesCarmen D Schweighofer, Kevin R Coombes, Tadeusz Majewski, et al.
Endocrine-Related Cancer|August 21, 2016
Genetic variants in thyroid cancer distant metastasesSteven E Justiniano, Joseph P McElroy, Lianbo Yu, et al.
Pageof 34

Showing results (281-290 of 334) with videos related to

Sort By:
Pageof 34
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapyMark S Carey, Roshan Agarwal, Blake Gilks, et al.
The Journal of Molecular Diagnostics : JMD|August 11, 2007
Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technologyLynne V Abruzzo, Lynn L Barron, Keith Anderson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2010
Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progressionJoan H Admirand, Ronald J Knoblock, Kevin R Coombes, et al.
Annals of Surgery|May 21, 2024
Extracellular Vesicle- MDM2 -DNA as a Potential Liquid Biopsy Biomarker for Disease Identification in Retroperitoneal LiposarcomaFederica Calore, Lucia Casadei, Patricia D Sarchet, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2016
Risk Factors of <sup>131</sup>I-Induced Salivary Gland Damage in Thyroid Cancer PatientsBrynn Hollingsworth, Leigha Senter, Xiaoli Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentationThomas Karn, Lajos Pusztai, Eugen Ruckhäberle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2011
Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patientsYang Xie, Guanghua Xiao, Kevin R Coombes, et al.
British Journal of Cancer|January 1, 1997
Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significanceA J Desai, Y A Luqmani, J E Walters, et al.
The Journal of Molecular Diagnostics : JMD|January 1, 2013
Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypesCarmen D Schweighofer, Kevin R Coombes, Tadeusz Majewski, et al.
Endocrine-Related Cancer|August 21, 2016
Genetic variants in thyroid cancer distant metastasesSteven E Justiniano, Joseph P McElroy, Lianbo Yu, et al.
Pageof 34